Kiromic Biopharma, Inc.
KRBPDelisted Nov 20, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001792581
Kiromic Biopharma, Inc. was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Aug 26, 2024; no institution reported holding it in 13F filings for Q3 2023; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in Kiromic Biopharma, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- +7 vs. Q2 2021
- Shares held
- 2.44M
- −37.5K (−1.5%) vs. Q2 2021
- Total value
- $7.49M
- −$4.42M (−37.1%) vs. Q2 2021
- New holders
- 10
- 8 more added
- Sold out
- 3
- 4 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KRBP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 5 | $6.13K |
| Q1 2023 | 7 | $78.2K |
| Q4 2022 | 12 | $145.5K |
| Q3 2022 | 16 | $90.3K |
| Q2 2022 | 17 | $200.0K |
| Q1 2022 | 20 | $1.73M |
| Q4 2021 | 21 | $3.82M |
| Q3 2021 | 23 | $7.49M |
| Q2 2021 | 16 | $11.9M |
| Q1 2021 | 13 | $3.34M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Kiromic Biopharma, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Kepos Capital LP | 767,000 | $2.35M | 0.16% | 00.0% | Unchanged |
| Sabby Management, LLC | 478,122 | $1.47M | 0.32% | −22,386−4.5% | Reduced |
| 1492 Capital Management LLC | 434,408 | $1.33M | 0.68% | +76,402+21.3% | Added |
| Vanguard Group Inc | 295,288 | $906.0K | 0.00% | +175,984+147.5% | Added |
| Intellectus Partners, LLC | 98,850 | $303.0K | 0.07% | +23,950+32.0% | Added |
| Zeke Capital Advisors, LLC | 56,899 | $175.0K | 0.01% | +40,000+236.7% | Added |
| LPL Financial LLC | 52,800 | $162.0K | 0.00% | +52,800 | New |
| Geode Capital Management, LLC | 51,728 | $158.0K | 0.00% | +51,728 | New |
| Redmond Asset Management, LLC | 46,370 | $142.0K | 0.04% | +1,034+2.3% | Added |
| BlackRock Inc. | 30,645 | $94.0K | 0.00% | +21,018+218.3% | Added |
| Citadel Advisors LLC | 26,683 | $82.0K | 0.00% | +26,683 | New |
| Virtu Financial LLC | 17,453 | $54.0K | 0.00% | +17,453 | New |
| K.J. Harrison & Partners Inc | 17,002 | $52.0K | 0.01% | +17,002 | New |
| State Street Corp | 16,686 | $51.0K | 0.00% | +16,686 | New |
| Warberg Asset Management LLC | 12,000 | $37.0K | 0.01% | −51,000−81.0% | Reduced |
| Shay Capital LLC | 12,000 | $37.0K | 0.01% | −13,000−52.0% | Reduced |
| Resources Investment Advisors, LLC. | 10,000 | $31.0K | 0.00% | +10,000 | New |
| WealthTrust Axiom LLC | 10,000 | $30.0K | 0.01% | +10,000 | New |
| Advisor Group Holdings, Inc. | 2,789 | $9.00K | 0.00% | +2,789 | New |
| Morgan Stanley | 1,200 | $4.00K | 0.00% | −2,000−62.5% | Reduced |
| Tower Research Capital LLC (TRC) | 810 | $2.00K | 0.00% | +810 | New |
| Wells Fargo & Company | 38 | $0 | 0.00% | +30+375.0% | Added |
| Harbour Investments, Inc. | 40 | $0 | 0.00% | +7+21.2% | Added |
| Altium Capital Management LP | 0 | $0 | 0.00% | −333,475−100.0% | Sold out |
| Murchinson Ltd. | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −60,000−100.0% | Sold out |